Home Cart Sign in  
Chemical Structure| 111-58-0 Chemical Structure| 111-58-0

Structure of Oleoylethanolamide
CAS No.: 111-58-0

Chemical Structure| 111-58-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Oleoylethanolamide is a lipid mediator and analog of anandamide that is involved in peripheral regulation of feeding. It is also a selective GPR55 agonist (EC50 values are 0.44, > 30 and > 30 μM at GPR55, CB1 and CB2 respectively) and PPARα agonist (EC50 = 120 nM).

Synonyms: N-Oleoylethanolamide; Oleamide MEA; NOE

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Oleoylethanolamide

CAS No. :111-58-0
Formula : C20H39NO2
M.W : 325.53
SMILES Code : CCCCCCCC/C=C\CCCCCCCC(NCCO)=O
Synonyms :
N-Oleoylethanolamide; Oleamide MEA; NOE
MDL No. :MFCD00045972
InChI Key :BOWVQLFMWHZBEF-KTKRTIGZSA-N
Pubchem ID :5283454

Safety of Oleoylethanolamide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Oleoylethanolamide

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03347890 Obesity Phase 4 Recruiting March 1, 2020 Switzerland ... More >> University Hospitals of Geneva Recruiting Geneva, Switzerland, 1206 Contact: Zoltan Pataky, MD       zoltan.pataky@hcuge.ch    Principal Investigator: Zoltan Pataky, MD          Sub-Investigator: Loic Locatelli, MD Less <<
NCT01851304 Obesity Overw... More >>eight Less << Not Applicable Completed - Italy ... More >> Department of Agriculture and Food Science Portici, Italy, 80055 Less <<
NCT02243657 Healthy Subjects ... More >> Pharmacokinetics of ASP3652 Pharmacodynamics of ASP3652 Less << Phase 1 Completed - Netherlands ... More >> PRA International Groningen, Netherlands, 9713GZ Less <<
NCT01223157 Obesity Not Applicable Completed - France ... More >> Service of Endocrinology, Diabetology, metabolic diseases - Hôpital du Haut Lévêque - CHU de BORDEAUX Bordeaux, France Less <<
NCT01092845 Healthy Sleep Phase 1 Completed - United States, New York ... More >> Pfizer Investigational Site New York, New York, United States, 10019 Less <<
NCT01958047 Pharmacokinetics ... More >> Pharmacodynamics Healthy Subjects Effect of Race Less << Phase 1 Completed - United Kingdom ... More >> Parexel Early Phase Clinical Unit Harrow, United Kingdom, H1 3UJ Less <<
NCT02889224 Cushing's Syndrome Not Applicable Completed - France ... More >> Service d'Endocrinologie, Hopital Haut-Leveque Pessac, France, 33600 Less <<
NCT01964651 Healthy Phase 1 Completed - Belgium ... More >> Merksem, Belgium Less <<
NCT03564379 Healthy Phase 1 Completed - United States, California ... More >> WCCT Global, LLC Cypress, California, United States, 90630 Less <<
NCT03407937 Hypnosis Endo... More >>cannabinoids Analgesia Less << Not Applicable Completed - Canada, Quebec ... More >> CRCHUS: Centre de recherche du centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H5N4 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.07mL

0.61mL

0.31mL

15.36mL

3.07mL

1.54mL

30.72mL

6.14mL

3.07mL

References

 

Historical Records

Categories